Floxuridine (NSC 27640)

For research use only. Not for use in humans.

目录号:S1299 别名: Deoxyfluorouridine, FUDR 中文名称:氟尿苷

Floxuridine (NSC 27640) Chemical Structure

CAS No. 50-91-9

Floxuridine (NSC 27640, Deoxyfluorouridine, FUDR) 是一种前体药物,在体内可迅速分解为5-fluorouracil。Floxuridine 可用于治疗各种癌症,特别是转移到肝脏的癌症。Floxuridine 可抑制 Poly(ADP-Ribose) polymerase、诱导DNA损伤和凋亡。Floxuridine 对HSV和CMV具有抗病毒作用。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 647.01 现货
RMB 782.46 现货
RMB 1449.63 现货
RMB 2439.19 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Floxuridine (NSC 27640)发表文献7篇:

产品安全说明书

DNA/RNA Synthesis抑制剂选择性比较

生物活性

产品描述 Floxuridine (NSC 27640, Deoxyfluorouridine, FUDR) 是一种前体药物,在体内可迅速分解为5-fluorouracil。Floxuridine 可用于治疗各种癌症,特别是转移到肝脏的癌症。Floxuridine 可抑制 Poly(ADP-Ribose) polymerase、诱导DNA损伤和凋亡。Floxuridine 对HSV和CMV具有抗病毒作用。
体外研究

Floxuridine呈现对PEPT1比相应的5'-O-单氨基酸酯前药更高的亲和力。[1] Floxuridine和Leucovorin联用导致人T淋巴细胞白血病细胞生长的协同抑制作用。[2] Floxuridine显著抑制[(3)H]-inosine和[(3)H]腺苷的的摄取(对照的60-70%),而它的氨基酸酯前体,包括缬氨酸,苯丙氨酸,Asp和赖氨酸酯,显著下降抑制效力(对照的10-30%)。[3] Floxuridine在36天抑制细胞增值超过对照细胞的50%,细胞数量和初始细胞密度相比增加了4倍。Floxuridine导致对体外培养的人眼球筋膜囊成纤维细胞增殖长时间延长。[4] Floxuridine是一种理想的肝动脉灌注(HAI)药物,由于其半衰期短,陡峭的剂量反应曲线,高总清除率和高肝提取。[5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CCRF-CEM cell NWTPZnh1T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= Mmn3WIV{fGWmIHnuJJZqfHKxIH\vdkB1cGViaX7obYJqfGmxbjDv[kBk\WyuIHfyc5d1cCCxZjDoeY1idiCWIHz5cZBpd2KuYYP0c4llKEOFUl[tR2VOKGOnbHygcIlv\SBqQWTDR{BES0xiMUG5LUwhUUN3ME2wMlUh|ryP MkfYNVE6ODl5MU[=
CCRF-CEM NVnxcZZ[T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MlnWTY4hfmm2cn:gZ49v[2WwdILheIlwdiC{ZYH1bZJm\CCob4KgOVAmKGmwaHnibZRqd25ib3[g[5Jwf3SqIH;mJIh2dWGwIHzleYtmdWmjIHPlcIwhdGmwZTDDR3JHNUOHTTD3bZRpKGiSQWCgLFAvOiC3bnn0M41NMSxiR1m1NF0xNjByME[g{txO MXixNVU6PzRyNB?=
LNCaP cells MX\DfZRwfG:6aXPpeJkh[XO|YYm= NYG0SHFNS3m2b4TvfIlkKGOxbnPlcpRz[XSrb36gbY4heHKxc4TheIUhe3CnY3nmbYMh[W62aXflckApWFODKTDwdo9lfWOrbnegbJVu[W5iTF7DZXAh[2WubIOsJGlEPTB;MD6wOlkzKM7:TR?= MlTWNVIyPjFzNUe=
TSU cells MkXjR5l1d3SxeHnjbZR6KGG|c3H5 NG\mfHFEgXSxdH;4bYMh[2:wY3XueJJifGmxbjDpckBvd25icILvd5RifGVic4DlZ4lncWNiYX70bYdmdiBqUGPBLUBxem:mdXPpcochcHWvYX6gWHNWKGOnbHzzMEBKSzVyPUCuNFU5KM7:TR?= M2HwSFEzOTZzMUW3
KBALB cell NIn1b5VEgXSxdH;4bYNqfHliYYPzZZk> NH\Db|dKdiC4aYTyc{Bk\WyuIHP5eI91d3irY3n0fUBi\2GrboP0JGtDSUyEIHPlcIwhdGmwZTCoeJJidnOob4Lt[YQh\mmkcn;icIF{fCC|YYLjc41iKGOnbHygcIlv\SluIFPDOVA:Pi5yMFWtNFUh|ryP MUKxNlYzODB5Nh?=
KBALB-STK cell MoOxR5l1d3SxeHnjbZR6KGG|c3H5 NHHJUFdKdiC4aYTyc{Bk\WyuIHP5eI91d3irY3n0fUBi\2GrboP0JGtDSUyELWPUT{Bk\WyuIHzpcoV{KGW6cILld5Nm\CCrbjDIV3YuOSCWSzygTWM2OD16LkiwSU0xPSEQvF2= NHTuTIsyOjZ{MEC3Oi=>
L1210 mouse leukemia cells MWXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NGG3bGEzPCCq MoSwS5Jwf3SqIHnubIljcXSrb36gbY4hVDF{MUCgcY92e2VibHX1b4VucWFiY3XscJMh[W[2ZYKgNlQhcCC2cnXheI1mdnRuIFnDOVA:OC5yMESxJO69VQ>? MUKxNVczQDF7Mx?=
L1210 mouse leukemia cells NWLQfpVFT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NU\hU5VDPDhiaB?= M4TXWWdzd3e2aDDpcohq[mm2aX;uJIlvKExzMkGwJI1wfXOnIHzleYtmdWmjIHPlcIx{KGGodHXyJFQ5KGi{IITy[YF1dWWwdDygTWM2OD1yLkCwNFY1KM7:TR?= MoC0NVE4OjhzOUO=
L5178Y cell MUHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MVrDc41x[XKjdHn2[UBqdmirYnn0bY9vKG:oIFy1NVc5YSClZXzsJIdzd3e2aDDpckB3cXS{bzCoZ49v[2WwdILheIlwdiC{ZYH1bZJm\CCob4KgOVAmKGmwaHnibZRqd25rLDDJR|UxRTBwMECwO|Yh|ryP Mny1Olc4QTByNx?=
L5178Y cells M4K0SGZ2dmO2aX;uJIF{e2G7 NH60RVlKdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gc4Yh[2:vcH;1coQhf2G|IHPhcIN2dGG2ZXSgc44hVDVzN{jZJINmdGy|IHL5JHsyPEOfTHX1JIlv[2:{cH;yZZRqd25uIFnDOVA:OiEQvF2= NGjUWHI5OjR4MkK5
L1210 mouse leukemia cells NIPZbHRHfW6ldHnvckBie3OjeR?= MoroNkBp Mkf4WIh6dWmmeXzheIUhe3mwdHjhd4UhcW6qaXLpeIlwdiCrbjDMNVIyOCCvb4Xz[UBt\XWtZX3pZUBk\WyuczDh[pRmeiB{IHjyJJRz\WG2bXXueEwhUUN3ME2wMlAxPzlizszN MoTDNVE4OjhzOUO=
LM cells NYnycGY2TnWwY4Tpc44h[XO|YYm= Ml3mNkBp M37NcnRpgW2rZInsZZRmKHO7boToZZNmKGmwaHnibZRqd25iaX6geIh6dWmmaX7lJItqdmG|ZTDk[YZq[2mnboSgUG0h[2WubIOgZYZ1\XJiMjDodkB1emWjdH3lcpQtKEmFNUC9OU41KM7:TR?= MoPtNVE4OjhzOUO=
HT1080 cells NFf6RmpHfW6ldHnvckBie3OjeR?= NXzq[FhVS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhVOTB6MDDj[YxteyCkeTDNWHQh[XO|YYmsJGlEPTB;MD6xPEDPxE1? MnHnNVc5ODR{M{G=
L1210 cells NYTtNWVpT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NU\SOWd{PzJiaB?= M4SxZWN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDMNVIyOCClZXzsd{BCXEOFIFPDUFIyQSCjc4Pld5Nm\CCjczDndo94fGhicnXkeYN1cW:wIHHmeIVzKDd{IHjyd{whUUN3ME2wMlAyOiEQvF2= MX:xO|k6PzNzOR?=
HL60 cells MXPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M3jzbVczKGh? NWThTo5FS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhNPjBiY3XscJMhSVSFQzDDR2whOjRyIHHzd4V{e2WmIHHzJIdzd3e2aDDy[YR2[3Srb36gZYZ1\XJiN{KgbJJ{NCCLQ{WwQVAvODF{IN88US=> NXzGSmJDOTd7OUezNVk>
CCRF-CEM cells NX\BWm46T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= Mn3HO|IhcA>? MXnDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1PSSk1ETU1iY3XscJMhSVSFQzDDR2whOTF7IHHzd4V{e2WmIHHzJIdzd3e2aDDy[YR2[3Srb36gZYZ1\XJiN{KgbJJ{NCCLQ{WwQVAvODF5IN88US=> NWC2b4R6OTd7OUezNVk>
L1210 cells M2DMfmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MmTMO|IhcA>? MorwR5l1d3O2YYTpZ{Bi[3Srdnn0fUBqdiCvb4Xz[UBNOTJzMDDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOnbHyg[5Jwf3SqIHHmeIVzKDd{IHjyd{whUUN3ME2wMlAyOiEQvF2= M2LNOlE5ODd6N{W3
HL60 cells NF\iNHlIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NIjo[pM4OiCq MnixR5l1d3O2YYTpZ{Bi[3Srdnn0fUBqdiCqdX3hckBJVDZyIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yh[2WubDDndo94fGhiYX\0[ZIhPzJiaILzMEBKSzVyPUCuNFEzKM7:TR?= NXvIe|JZOThyN{i3OVc>
CCRF-CEM cells NYjiUHpbT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M2nNOFczKGh? NV;GNHRCS3m2b4P0ZZRq[yCjY4Tpeol1gSCrbjDoeY1idiCFQ2LGMWNGVSClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJINmdGxiZ4Lve5RpKGGodHXyJFczKGi{czygTWM2OD1yLkCxO{DPxE1? NX64VoVwOThyN{i3OVc>
CCRF-CEM cells M{i2SmZ2dmO2aX;uJIF{e2G7 NEjIVYc1QCCq M2roNGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDR3JHNUOHTTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCwOlMyKM7:TR?= M1TmXlE6PzR2OEW4
K562 cells NVPQZlJsTnWwY4Tpc44h[XO|YYm= NH7oR3Q1QCCq MlzLRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFu1OlIh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE44QTR|MzFOwG0> M2W3PFE6PzR2OEW4
MOLT4 cells NH\R[lJHfW6ldHnvckBie3OjeR?= MVy0PEBp MkfHRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3PUHQ1KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvODN7OEGg{txO MmDvNVk4PDR6NUi=
RPMI8266 cells NUi4O4xpTnWwY4Tpc44h[XO|YYm= MoL6OFghcA>? NFrCW3FCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gVnBOUTh{Nk[gZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD63PVQ{OyEQvF2= MnT1NVk4PDR6NUi=
human SR cells NUDTWIVbTnWwY4Tpc44h[XO|YYm= Mk\YOFghcA>? NHvIXnhCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV3Ih[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xOTJ3OTFOwG0> MYGxPVc1PDh3OB?=
A549 cells MUDGeY5kfGmxbjDhd5NigQ>? MV20PEBp MYTBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUW0PUBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlAyOjV7IN88US=> NHnpT2EyQTd2NEi1PC=>
EKVX cells MVvGeY5kfGmxbjDhd5NigQ>? MVm0PEBp NFGwNFBCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gSWtXYCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yOCEQvF2= Mn\4NVk4PDR6NUi=
HOP62 cells MYrGeY5kfGmxbjDhd5NigQ>? M4juPFQ5KGh? NYTCNJZtSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhQWDZ{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMEK1NVIh|ryP NWXJfI1zOTl5NES4OVg>
HOP92 cells M3PuU2Z2dmO2aX;uJIF{e2G7 MYK0PEBp NXe5NWNMSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhQWDl{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwN{m0N|Mh|ryP M{XvTVE6PzR2OEW4
NCI-H226 cells NETEendHfW6ldHnvckBie3OjeR?= MlziOFghcA>? M2q2WWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOR2kuUDJ{NjDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeR?= NVjZWGh5OTl5NES4OVg>
NCI-H23 M320bmZ2dmO2aX;uJIF{e2G7 M2\jbFQ5KGh? MmT4RY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF7DTU1JOjNiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OTBizszN MnLRNVk4PDR6NUi=
NCI-H322 MX;GeY5kfGmxbjDhd5NigQ>? M334SFQ5KGh? NFzxNG1CdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh|MkLNJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuOVAyOTlizszN MkXZNVk4PDR6NUi=
NCI-H460 MXLGeY5kfGmxbjDhd5NigQ>? MWi0PEBp M1zSW2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOR2kuUDR4MDDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkWwNVE6KM7:TR?= MVixPVc1PDh3OB?=
NCI-H522 NUjhNYlDTnWwY4Tpc44h[XO|YYm= MVq0PEBp M4PEPGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOR2kuUDV{MjDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCwNkDPxE1? M1TvOVE6PzR2OEW4
COLO205 cells MmX2SpVv[3Srb36gZZN{[Xl? NGnB[oI1QCCq MU\BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQ1;MU|IxPSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0zNjVzMUi5JO69VQ>? MVGxPVc1PDh3OB?=
HCC2998 cells M{DheGZ2dmO2aX;uJIF{e2G7 MlnoOFghcA>? NEfVbWVCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTGNEOjl7ODDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1zLkW4OFg6KM7:TR?= NHqxdVUyQTd2NEi1PC=>
HCT116 cells M3njeGZ2dmO2aX;uJIF{e2G7 M3K0NVQ5KGh? NXLFbVZMSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhEXDFzNjDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCwNUDPxE1? MXuxPVc1PDh3OB?=
HCT15 cells M1jnO2Z2dmO2aX;uJIF{e2G7 M1\iOFQ5KGh? MULBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFPUNVUh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4yOjV6OTFOwG0> M2WwRlE6PzR2OEW4
HT-29 cells NXXEfJNoTnWwY4Tpc44h[XO|YYm= MmXhOFghcA>? M4W3SmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIWE0zQSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yNjl7NUK2JO69VQ>? NWnaTGFCOTl5NES4OVg>
KM12 cells NV3DXXRPTnWwY4Tpc44h[XO|YYm= Mn\zOFghcA>? MnfwRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFvNNVIh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9Nk42OTF6OTFOwG0> MnjqNVk4PDR6NUi=
SW620 cells NGTBTolHfW6ldHnvckBie3OjeR?= M175SFQ5KGh? NXLtR|IySW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNYPjJyIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTZwM{C5OVch|ryP MlqxNVk4PDR6NUi=
SF268 cells Mke0SpVv[3Srb36gZZN{[Xl? MV20PEBp MWDBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1[yOlgh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NVAh|ryP MUWxPVc1PDh3OB?=
SF295 cells NIG0emhHfW6ldHnvckBie3OjeR?= NEG4TYw1QCCq MYLBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1[yPVUh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xOTJ3OTFOwG0> M2jSTFE6PzR2OEW4
SF539 cells MX3GeY5kfGmxbjDhd5NigQ>? MlnzOFghcA>? MWXBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1[1N|kh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xOzl6MTFOwG0> MWmxPVc1PDh3OB?=
SNB19 cells MYDGeY5kfGmxbjDhd5NigQ>? NV7heJpnPDhiaB?= M4n3VWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTUmIyQSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yNjl7NUK2JO69VQ>? NGi0VlMyQTd2NEi1PC=>
SNB75 cells M1j2ZWZ2dmO2aX;uJIF{e2G7 M4PtSFQ5KGh? M2[yZmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTUmI4PSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjF7OUWzJO69VQ>? M2jZN|E6PzR2OEW4
U251 cells NX3Q[pYzTnWwY4Tpc44h[XO|YYm= M3H3PVQ5KGh? NUHERoI{SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHUzPTFiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5zMkW4PUDPxE1? NHn1WngyQTd2NEi1PC=>
LOXIMVI cells MXnGeY5kfGmxbjDhd5NigQ>? MYO0PEBp NYr3XVl3SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGxQYEmPVlmgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD6wNlUyOiEQvF2= NHX3WY0yQTd2NEi1PC=>
MALME-3M cells Ml;LSpVv[3Srb36gZZN{[Xl? M3z3NFQ5KGh? MmLrRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3BUG1GNTOPIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTdwOUSzNlgh|ryP MYexPVc1PDh3OB?=
M14 cells NVrtPWQ{TnWwY4Tpc44h[XO|YYm= NVSyNGt5PDhiaB?= M3ryUmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNNVQh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4yPTh2OTFOwG0> NVvXNY53OTl5NES4OVg>
SK-MEL-2 cells MWXGeY5kfGmxbjDhd5NigQ>? MoT4OFghcA>? M3vsVmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT{1OTUxvMjDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1zMDFOwG0> MofSNVk4PDR6NUi=
SK-MEL-28 cells NYjW[5JtTnWwY4Tpc44h[XO|YYm= NHG4[Wc1QCCq NEDUVmNCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV2suVUWOLUK4JINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUGuPVk2OjZizszN MoX3NVk4PDR6NUi=
SK-MEL-5 cells NY\tSIM5TnWwY4Tpc44h[XO|YYm= NGix[mI1QCCq NYTYfJV6SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNMNU2HTD21JINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuNVk6PTNizszN M4nsT|E6PzR2OEW4
UACC257 cells NG[0UXpHfW6ldHnvckBie3OjeR?= MorQOFghcA>? NIPN[oVCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gWWFESzJ3NzDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1|LkG2NlI5KM7:TR?= NV3yUoQ4OTl5NES4OVg>
UACC62 cells MUfGeY5kfGmxbjDhd5NigQ>? NYLvTGpbPDhiaB?= NXLGO2ZRSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHVCS0N4MjDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1yLkCzPVgyKM7:TR?= NYHoN3FpOTl5NES4OVg>
IGROV1 cells M2TRVGZ2dmO2aX;uJIF{e2G7 M4LGWFQ5KGh? MnLmRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFnHVm9XOSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0zNjVzMUi5JO69VQ>? Mlq3NVk4PDR6NUi=
OVCAR-3 cells MVHGeY5kfGmxbjDhd5NigQ>? MmnHOFghcA>? NHLtOVdCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gU3ZESVJvMzDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1{LkWxNVg6KM7:TR?= M3G5ZlE6PzR2OEW4
OVCAR4 cells M1fJcGZ2dmO2aX;uJIF{e2G7 MXq0PEBp NV7LRZNySW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJG9XS0GUNDDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1zMDFOwG0> NYrvRXlPOTl5NES4OVg>
OVCAR5 cells MVzGeY5kfGmxbjDhd5NigQ>? M3nldlQ5KGh? NHG5PHRCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gU3ZESVJ3IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTZwM{C5OVch|pyv NXLER2czOTl5NES4OVg>
OVCAR8 cells M{XEdWZ2dmO2aX;uJIF{e2G7 NETOem81QCCq M{TtU2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDPWmNCWjhiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5zMkW4PUDPxE1? M1jHdFE6PzR2OEW4
SKOV3 cells NH[yXnBHfW6ldHnvckBie3OjeR?= M1HacVQ5KGh? M{\1RWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT29XOyClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yNjl7NUK2JO69VQ>? MnnhNVk4PDR6NUi=
786-0 cells Mk[zSpVv[3Srb36gZZN{[Xl? M{njcFQ5KGh? NF;kWW9CdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gO|g3NTBiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5zIN88US=> MmTlNVk4PDR6NUi=
A498 cells NEfxdGVHfW6ldHnvckBie3OjeR?= MXy0PEBp NELYXpdCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gRVQ6QCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yNjJ3OEmzJO69VQ>? NGHi[pQyQTd2NEi1PC=>
ACHN cells NVPJfoF{TnWwY4Tpc44h[XO|YYm= NV6yNGt[PDhiaB?= NVPTN5oySW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGFEUE5iY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5yM{G2NkDPxE1? NHSxWJEyQTd2NEi1PC=>
Caki1 cells MV;GeY5kfGmxbjDhd5NigQ>? M{Cyb|Q5KGh? MkG2RY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPhb4kyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvODNzNkKg{txO NYjJeXdLOTl5NES4OVg>
SN12C cells M1i0fWZ2dmO2aX;uJIF{e2G7 NHrybnc1QCCq MV\BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU16xNmMh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4yQTl3MzFOwG0> NXvYO5dXOTl5NES4OVg>
TK10 cells M{KzZ2Z2dmO2aX;uJIF{e2G7 MXG0PEBp MWLBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVFuxNEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME21MlAyOTh5IN88US=> M1rnelE6PzR2OEW4
UO31 cells M1XaRmZ2dmO2aX;uJIF{e2G7 NGLGdJc1QCCq NWH6Sms6SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHVQOzFiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5zMkW4PUDPxE1? NVPIVIxnOTl5NES4OVg>
PC3 cells NVnQdJBvTnWwY4Tpc44h[XO|YYm= NWG2SWFXPDhiaB?= MWHBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuN|E3OjNizszN NV\RSHZOOTl5NES4OVg>
DU145 cells M2qzU2Z2dmO2aX;uJIF{e2G7 NFvNUVE1QCCq MVnBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iRGWxOFUh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4zPTFzOTFOwG0> MoGxNVk4PDR6NUi=
MCF7 cells M4e4dmZ2dmO2aX;uJIF{e2G7 MUG0PEBp MVHBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlAxPjNzIN88US=> M3\pU|E6PzR2OEW4
NCI/ADR-RES cells NVfNcWtFTnWwY4Tpc44h[XO|YYm= NXXFbZVKPDhiaB?= MWHBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTlPJM2FFWi2URWOgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MT6yOVg6OyEQvF2= MnjqNVk4PDR6NUi=
MDA-MB-231 cells NE\m[|NHfW6ldHnvckBie3OjeR?= MVe0PEBp M2\NZWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUOuPVgyODdizszN NHfvfHQyQTd2NEi1PC=>
Hs 578T cells MXPGeY5kfGmxbjDhd5NigQ>? M1vWR|Q5KGh? NFW5NJlCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTJMhPTd6VDDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1|Lkm4NVA4KM7:TR?= Mn70NVk4PDR6NUi=
MDA-MB-435 cells MWPGeY5kfGmxbjDhd5NigQ>? MkmyOFghcA>? MknyRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi12M{WgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;Mz6xOlIzQCEQvF2= NILGOIoyQTd2NEi1PC=>
MDA-N cells NYjZS3dMTnWwY4Tpc44h[XO|YYm= MmrPOFghcA>? M4L1S2FvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuViClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yNjJ3OEmzJO69VQ>? NEnQT2kyQTd2NEi1PC=>
BT549 cells NVrBTVdKTnWwY4Tpc44h[XO|YYm= M2DZVlQ5KGh? M2rtfmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDCWFU1QSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yKM7:TR?= MX:xPVc1PDh3OB?=
T47D cells NG\6fnhHfW6ldHnvckBie3OjeR?= NXPKVoZPPDhiaB?= MmPaRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGS0O2Qh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NU4zPTh7MzFOwG0> NYDyUXIzOTl5NES4OVg>
HepG2 cells MUXDfZRwfG:6aXPpeJkh[XO|YYm= M1vwVVczKGh? NFzQRXNEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\XCJMjDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVE5Njh2IN88US=> NIXQ[XgyQTlzN{WyPC=>
A549 cells M{TlSmN6fG:2b4jpZ4l1gSCjc4PhfS=> NVXGVlMyPzJiaB?= MoezR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBGSzVyPUmuO|Qh|ryP NFnHT4oyQTlzN{WyPC=>
LAC cells MoDWR5l1d3SxeHnjbZR6KGG|c3H5 NXPTW|RRPzJiaB?= M2jpVWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGxCSyClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBGSzVyPUOyMlA6KM7:TR?= M1\3eFE6QTF5NUK4
HeLa cells Ml;6R5l1d3SxeHnjbZR6KGG|c3H5 Mny3O|IhcA>? NFrBdIlEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEWFNUC9NVAvOjZizszN NInVT5kyQTlzN{WyPC=>
MDA-MB-231 cells NGnXO5REgXSxdH;4bYNqfHliYYPzZZk> NHzpcXpEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJI93\XKneIDy[ZN{cW6pIIXyc4tqdmG|ZTDwcIF{dWmwb3flckBi[3SrdnH0c5ItKEmFNUC9NE4zOSEQvF2= NGfNO4ozODN4M{GzNC=>
human ACHN cells NIPXVIJHfW6ldHnvckBie3OjeR?= NG\HVJFCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gRWNJViClZXzsd{BjgSCVUlKgZZN{[XluIFfJOVA:Oi5zIN88US=> M{XlclIxPzN{OEGw
PC3 cells NF3DRXdHfW6ldHnvckBie3OjeR?= MmnLRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDN{Bk\WyuczDifUBUWkJiYYPzZZktKEeLNUC9OE46PyEQvF2= NIjM[|AzODd|MkixNC=>
MDA-MB-231 cells MkXGSpVv[3Srb36gZZN{[Xl? MVfBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVTBMW1DNTJ|MTDj[YxteyCkeTDTVmIh[XO|YYmsJGdKPTB;MD6xOkDPxE1? MlezNlA4OzJ6MUC=
FM3A cells M1;vcmZ2dmO2aX;uJIF{e2G7 M1m4PVIh\GG7cx?= NV:5UZAyS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KG2xdYPlJGZOO0FiY3XscJMh[W[2ZYKgNkBl[Xm|IHL5JINwfWy2ZYKgZ492dnSrbnegZY5idHm|aYOsJGlEPTB;MD6wNFk1KM7:TR?= MWiyNVM{ODBzNB?=
HeLa cells M3\rW2Z2dmO2aX;uJIF{e2G7 MYLDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSHXMZUBk\WyuczDpckBxemW|ZX7j[UBw\iB{MDD1UUB1cHmvaXTpcoUtKEmFNUC9PE42KM7:TR?= MmPLNlE{OzByMUS=
LLC cells M{TFcmN6fG:2b4jpZ4l1gSCjc4PhfS=> NIq3PZUzPCCq MV3DfZRwfG:6aXPpeJkh[WejaX7zeEBud3W|ZTDMUGMh[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IILld4F7fXKrbjDhd5NigSxiSVO1NF0yPC5{IN88US=> MmPTNlE2OzZ2NEi=
LLC cells MVPDfZRwfG:6aXPpeJkh[XO|YYm= MlrVO|IhcA>? NVvmZ5JUS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVEyFIHPlcIx{KGGodHXyJFczKGi{czDifUBz\XOjeoXybY4h[XO|YYmsJGlEPTB;MjFOwG0> MlPZNlE2OzZ2NEi=
RAW264.7 cells MWrDfZRwfG:6aXPpeJkh[XO|YYm= NWSxU5VjPzJiaB?= NGjEXHFEgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UBTSVd{NkSuO{Bk\WyuczDh[pRmeiB5MjDodpMh[nlicnXzZZp2emmwIHHzd4F6NCCLQ{WwQVMxKM7:TR?= MXqyNVU{PjR2OB?=
A549 cells MV;DfZRwfG:6aXPpeJkh[XO|YYm= NWnibYcxPzJiaB?= MnX3R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bie3Onc4Pl[EBieyClZXzsJJZq[WKrbHn0fUBi\nSncjC3NkBpenNiYomgW3NVNThiYYPzZZktKEmFNUC9NE4xPDdizszN Mlq1NlIzPDh6NU[=
A2780 cells MVjDfZRwfG:6aXPpeJkh[XO|YYm= MkW2OUBl[Xm| M{PGTGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGEzPzhyIHPlcIx{KGGodHXyJFUh\GG7czDifUBOXFRiYYPzZZktKEmFNUC9NE4xOjZizszN NHvHWXczOjd|OE[zOi=>
LMTK cells M1\VfGN6fG:2b4jpZ4l1gSCjc4PhfS=> NEf4Opg2KGSjeYO= NVfOeY82S3m2b4TvfIlkcXS7IHHnZYlve3RidHj5cYllcW6nIHvpcoF{\S2mZX\pZ4lmdnRibX;1d4UhVE2WSzDj[YxteyCjZoTldkA2KGSjeYOgZpkhVVSWIHHzd4F6NCCLQ{WwQVQvPSEQvF2= NF\qRmYzOjd|OE[zOi=>
A549 cells NYHVNVNpS3m2b4TvfIlkcXS7IHHzd4F6 NXXTNWJoPzJiaB?= NHflVINEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPTR7IHPlcIx{KGGodHXyJFczKGi{czDifUBucWO{b4DsZZRmKHKnYXTldkBu\XSqb3SsJGlEPTB;MD6wNVI1KM7:TR?= NVLOU4NROjJ6NEewNVk>
CEM cells MmnrSpVv[3Srb36gZZN{[Xl? NHvTUJU4OiCq NIPaNYJEgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gR2VOKGOnbHzzJIV5eHKnc4PpcochcHWvYX6gSW5VOSC2cnHud5BwenSncjDh[pRmeiB5MjDodpMh[nliY3XscEBkd3WwdHnu[{BqdiCycnXz[Y5k\SCxZjDORm1RWixiSVO1NF0xNjhizszN MYKyNVg6Ojh{OR?=
Hela cells MUTGeY5kfGmxbjDhd5NigQ>? NYnD[nFvPzJiaB?= MVXDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSHXMZUBk\WyuczDh[pRmeiB5MjDodpMh[nliY3XscEBkd3WwdHnu[{whUUN3ME2wMlA2KM7:TR?= M4D1Z|IyQDl{OEK5
CEM/0 cells MY\GeY5kfGmxbjDhd5NigQ>? M1;NV|czKGh? M3u5bmN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDSW0wOCClZXzsd{Bi\nSncjC3NkBpenNiYomgZ4VtdCClb4XueIlv\yxiSVO1NF0xNjB{MjFOwG0> NFnzNXMzOTh7MkiyPS=>
L1210/0 cells NVzOenVFTnWwY4Tpc44h[XO|YYm= NWXVbWM6PDhiaB?= MVnDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViTEGyNVAwOCClZXzsd{Bi\nSncjC0PEBpenNiYomgZ4VtdCClb4XueIlv\yxiSVO1NF0xNjByMEmg{txO M3y0PVIyQDl{OEK5
MCF7 cells MYTDfZRwfG:6aXPpeJkh[XO|YYm= NVSxWHBTPzJiaB?= MkHJR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bi\nSncjC3NkBpenNiYomgV3JDKGG|c3H5MEBKSzVyPUGyMlE6KM7:TR?= MUeyN|g3PzZyMx?=
HeLa cells NX7RT5U4S3m2b4TvfIlkcXS7IHHzd4F6 MoS0O|IhcA>? M2e1TWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmVGFiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JHNTSiCjc4PhfUwhUUN3ME22MlUh|ryP MVGyN|g3PzZyMx?=
HL60 cells MWXQdo9tcW[ncnH0bY9vKGG|c3H5 NY\pfWpqPzJiaB?= NEK5RnhCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjMOlAh[2WubIOgZZN{\XO|ZXSgZZMh\3Kxd4ToJIlvcGmkaYTpc44h[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2wMlI1KM7:TR?= MYiyOVY1PDZ5NB?=
SW707 cells NF\z[2JRem:uaX\ldoF1cW:wIHHzd4F6 MkL0O|IhcA>? MVrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFOZN{C3JINmdGy|IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;uJIFnfGW{IEeyJIhzeyCkeTDTVmIhdWW2aH;kMEBKSzVyPUKzMlg3KM7:TR?= NWTaWYVuOjV4NES2O|Q>
LoVo cells NGr3SpRRem:uaX\ldoF1cW:wIHHzd4F6 MVW3NkBp NXXrV5pmSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDMc3ZwKGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGGodHXyJFczKGi{czDifUBUWkJibXX0bI9lNCCLQ{WwQVE6NjB5IN88US=> NV3td5M{OjV4NES2O|Q>
BALB/3T3 cell NEHQPW1Rem:uaX\ldoF1cW:wIHHzd4F6 MnfPO|IhcA>? NX3VdJNTSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDCRWxDNzOWMzDj[YxteyCjc4Pld5Nm\CCjczDndo94fGhiaX7obYJqfGmxbjDh[pRmeiB5MjDodpMh[nliU2LCJI1mfGixZDygTWM2OD1{Mz65JO69VQ>? NHjUd5AzPTZ2NE[3OC=>
HFF cells MkPQSpVv[3Srb36gZZN{[Xl? M37tVFczKGh? NEfLfm5CdnSrcHHyZZNqfGmlIHHjeIl3cXS7IHHnZYlve3RiVH;4c5Bt[XOvYTDnc45lcWliQWTDR{A2ODh|OTDpcoZm[3SnZDDpckBJTkZiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JIJmfGFvZ3HsZYN1d3OrZHHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvQTFizszN NFzVd2cyPzZ7OE[xPC=>
CCRFCEM cells MXTGeY5kfGmxbjDhd5NigQ>? NXLOdZZzS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGNEWk[FRV2gZ4VtdHNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNlkh|ryP Mkf6NVc5ODR{M{G=
RXF393 cells MWHGeY5kfGmxbjDhd5NigQ>? MUO0PEBp M4PoOGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDSXGY{QTNiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:Oy57OEGwO{DPxE1? NY[2PYxpOTl5NES4OVg>
HL-60(TB) cells M4LHT2Z2dmO2aX;uJIF{e2G7 MXq0PEBp MXLBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFytOlApXEJrIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMUm5OVMh|ryP NUjmdI1POTl5NES4OVg>
L1210 cells M{O1dWZ2dmO2aX;uJIF{e2G7 MV:xOUBucW6| MYTJcohq[mm2aX;uJI9nKHSqeX3p[Jlt[XSnIIP5cpRp[XOnIHnuJI1wfXOnIFyxNlExKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[geJJqfGm3bTDy[Yxm[XOnIH\yc40hYzVvM1jd[IVwgHm3cnnkbY5mKGGodHXyJJBz\WmwY4XiZZRqd25iZn;yJFE2KG2rboOgZpkhdGmzdXnkJJNkcW62aXzsZZRqd25iY3;1cpRqdmduIFnDOVA:OC5yMEC2JO69VQ>? NGrnelUzOTN|MECxOC=>
Colo-357 cells MmjoSpVv[3Srb36gZZN{[Xl? NF\wcY0yODBizszN M4jZN|E2KG2rboO= M4X5O2FkfGm4aYT5JIF1KE2UUEWgbY4hcHWvYX6gR49tdy1|NUegZ4VtdHNiYYPz[ZN{\WRiYYOgOU1H\FWPUDDhZ4N2dXWuYYTpc44h[XRiMUCwJJVOKGGodHXyJFE2KG2rboO= M330ZlIxQTNyMUKz
KB cells M4fGVWN6fG:2b4jpZ4l1gSCjc4PhfS=> MV63NkBp MYHDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDLRkBk\WyuczDh[pRmeiB5MjDodpMh[nliU2LCJIF{e2G7LDDJR|UxRThwNkmg{txO NYPJUplvOjN6Nke2NFM>

... Click to View More Cell Line Experimental Data

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

溶解度 (25°C)

体外 DMSO 49 mg/mL (199.03 mM)
Water 49 mg/mL (199.03 mM)
Ethanol '''10 mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 246.19
化学式

C9H11FN2O5

CAS号 50-91-9
储存条件 粉状
溶于溶剂
别名 Deoxyfluorouridine, FUDR

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01042691 Completed Drug: Oxaliplatin Unresectable Colorectal Liver Metastases David Bartlett|The Pittsburgh Foundation|Sanofi|University of Pittsburgh May 2003 Phase 1
NCT00695201 Completed Drug: Floxuridine Oxaliplatin CPT-11 Colon Cancer|Rectal Cancer Memorial Sloan Kettering Cancer Center|University of Medicine and Dentistry of New Jersey|Rutgers The State University of New Jersey|Sanofi August 2000 Phase 1

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

DNA/RNA Synthesis Signaling Pathway Map

相关DNA/RNA Synthesis产品

Tags: 购买Floxuridine (NSC 27640) | Floxuridine (NSC 27640)供应商 | 采购Floxuridine (NSC 27640) | Floxuridine (NSC 27640)价格 | Floxuridine (NSC 27640)生产 | 订购Floxuridine (NSC 27640) | Floxuridine (NSC 27640)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID